COX-2 selective inhibitors on severe market competition.

Published: 2001-05-14 06:59:00
Updated: 2001-05-14 06:59:00
A new NSAID drug market has shown a severe competition on the market led by 4 major COX-2 selective inhibitors including Celebrex by Pharmacia/Pfizer, Vioxx by MSD and Mobic by Boehringer Ingelheim.

Especially Celebrex and Vioxx severe competed each other, focusing their marketing strategies o...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.